跳至主要内容
临床试验/IRCT20090117001556N144
IRCT20090117001556N144招募中2 期

Evaluating the effect of sulforaphane supplementation in women with Polycystic ovary syndrome (PCOS) on depression, insulin resistance, and lipid profile change

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • Diagnosis of PCOS according to Rotterdam
  • Mild to moderate depression
  • 18-40 years old
  • BMI = or > 25
  • High blood fat
  • Disruption of Glucose tolerance test

排除标准

  • Lactation or gestation
  • Metabolic or thyroid dysfunction
  • Hyperprolactinemia
  • Hypercortisolemia
  • Severe depression
  • CNS drugs used such as antidepressants or anxiolytics
  • Insulin administration
  • Uncontrolled blood glucose level
  • Intense physical activity
  • History of severe stress
  • Emotional failure or hospitalization in recent past
  • History of mental health problems in first-degree relatives

研究者

相似试验

The effect of sulforaphane on depression in women... | 临床试验